AboutPricingLoginBook a demo
AboutPricingLoginBook a demo

EVA Pharma

Ownership
Private
Therapeutic Areas
GastroenterologyPulmonologyCardiovascularPsychiatryMen's HealthMetabolic DisordersOphthalmologyEndocrinologyDermatologyOtherWomen's HealthOncologyNeurologyInfectious Diseases
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Small moleculesgenericsbranded genericsOTC medicinesherbal medicinesdietary supplementsimmunosuppressantsinsulin

EVA Pharma General Information

EVA Pharma is a leading pharmaceutical manufacturer in the Middle East and Africa region with a global reach, exporting to over 40 countries including the European Union. Their facilities have received approvals from various international regulatory authorities including the European Medicines Agency, Health Canada, and regional authorities in the Middle East.

Contact Information

Website
https://www.evapharma.com/
Primary Industry
Biotech
Corporate Office
Cairo,
Egypt

Drug Pipeline

No pipeline data available

For full access to EVA Pharma's pipeline data

Book a demo

Key Partnerships

Eli Lilly and Company (for insulin glargine manufacturing), Vodafone Business

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

EVA Pharma Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view EVA Pharma's complete valuation and funding history, request access »

EVA Pharma Financial Metrics

See full profile
Book a demo
OverviewDrug PipelineTechnologiesPartnershipsFundingCompetitorsAnalysisPatentsLicensing Deals